To receive the Femtech World newsletter, sign up here.
News
New partnership to improve IVF testing
The collaboration is hoped to help more people access preimplantation genetic testing

The Australian biotech company GenEmbryomics has entered a partnership with a leading provider of preimplantation genetic testing in a bid to “transform” IVF.
Pre-implantation genetic diagnosis (PGD) is a technique that involves testing cells from embryos created outside the body by IVF for a genetic disorder.
Through their partnership, GenEmbryomics and Progenesis aim to help more people benefit from PGD with whole genome sequencing to fertility patients.
Progenesis says it will “leverage” its laboratory and facilities, while GenEmbryomics will serve as the preferred provider of its Panacea-GenomeScreen™ PGT-WGS test.
The Panacea-GenomeScreen™ PGT-WGS test allows IVF patients to screen embryos for more than 2500 genetic disorders that are life-threatening or cause severe disabilities.
The test, which can be used for standard IVF embryos as well as intracytoplasmic sperm injection (ICSI) embryos, is anticipated to reduce IVF costs for many patients compared to other tests, through higher testing accuracy increasing greater IVF success rates.
“Partnering with GenEmbryomics marks a pivotal step in our unwavering commitment to providing the premier IVF testing service,” said Nabil Arrach, founder and CEO of Progenesis.
“Providing the best testing technologies is crucial for delivering the greatest success rate to fertility patients. Together, we will work tirelessly to educate providers and patients on the immense value of combining PGT-A screening with GenEmbryomics’ advanced PGT-WGS.”
Nick Murphy, managing director of GenEmbryomics, said: “We are ecstatic to partner with Progenesis, a leader in IVF whose track-record in making IVF testing available to everyone speaks for itself.
“By combining our expertise and resources, we are bringing the most advanced IVF genomics technology ever developed to patients.
“Through this partnership, we aim to accelerate the adoption of this groundbreaking innovation, to help more patients achieve their dream of holding a healthy baby in their arms.”
Santiago Munne, the developer of the world’s first PGT-A test, current scientific director of Progenesis and president of Homu Health Ventures – an investor in GenEmbryomics, added: “We now have the ultimate test in embryo diagnosis, a test that can give information to future parents not only on which embryo is free of genetic disease but that can be used for their newborn baby’s lifetime health management”.
The partnership is expected to commence immediately and will continue for an initial period of 12 months, with expected renewal based on the mutual agreement of both parties.
Menopause
AI maps how reproductive organs age differently during menopause
Cancer
Ovarian cancer cases rising among younger adults, study finds

Ovarian cancer cases are rising among younger adults in England, with bowel cancer showing a similar pattern, a new study suggests.
Researchers said excess weight is a key contributor, but is unlikely on its own to explain the pattern.
The authors wrote: “These patterns suggest that while similar risk factors across ages are likely, some cancers may have age-specific exposures, susceptibilities, or differences in screening and detection practices.”
They added: “Although overweight and obesity are linked to 10 of the 11 cancers evaluated and account for a substantial proportion of cancer cases, both BMI-attributable and BMI-non-attributable incidence rates have increased, though the latter more slowly, suggesting other contributors.”
The study analysed cancer incidence, meaning new diagnoses, in England between 2001 and 2019 across more than 20 cancer types, comparing adults aged 20 to 49 with those aged 50 and over.
Among younger women, cases of 16 out of 22 cancers increased significantly over the period, while among younger men, 11 out of 21 cancers increased significantly.
In particular, there was a significant rise in 11 cancers with known behavioural risk factors among adults under 50. These were thyroid, multiple myeloma, liver, kidney, gallbladder, bowel, pancreatic, endometrial, mouth, breast and ovarian cancers.
Rates of all 11 also rose significantly among adults aged 50 and over, with the notable exceptions of bowel and ovarian cancer.
Five cancers, endometrial, kidney, pancreatic, multiple myeloma and thyroid cancer, increased significantly faster in younger than in older women, while multiple myeloma increased faster in younger than in older men.
The researchers looked at established risk factors including smoking, alcohol intake, diet, physical inactivity and body mass index, a measure used to assess whether someone is underweight, a healthy weight, overweight or obese.
With the exception of mouth cancer, all 11 cancers were associated with obesity. Six, liver, bowel, mouth, pancreatic, kidney and ovarian, were also linked to smoking.
Four, liver, bowel, mouth and breast, were associated with alcohol intake. Three, bowel, breast and endometrial, were linked to physical inactivity, and one, bowel, was associated with dietary factors.
But apart from excess weight, trends in those risk factors over the past one to two decades were stable or improving among younger adults.
That suggests other factors may also play a part, including reproductive history, early-life or prenatal exposures, and changes in diagnosis and detection.
The study noted that red meat consumption fell among younger adults, while fibre intake remained stable or slightly improved in both sexes between 2009 and 2019, although more than 90 per cent of younger adults were still not eating enough fibre in 2018.
Established behavioural risk factors accounted for a substantial share of cancer cases.
Excess weight was the risk factor associated with most cancers in 2019, ranging from 5 per cent for ovarian cancer to 37 per cent for endometrial cancer.
The researchers said the findings were based on observational data, meaning the study could identify patterns but could not prove cause and effect.
They also noted there were no consistent long-term national data for several risk factors, that the analysis was limited to England rather than the UK, and that cancer remains far more common overall in older adults despite the rise in cases among younger people.
Pregnancy
Early miscarriage care could prevent 10,000 pregnancy losses a year, study finds
Entrepreneur7 days agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Fertility2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health1 week agoLifting weights shows mental health and cognitive benefits in older women, study finds
Menopause2 weeks agoMore research needed to understand link between brain fog and menopause, expert says
News4 weeks agoCopper coil vs Mirena: Which is right for you?














